Financhill
Sell
10

KROS Quote, Financials, Valuation and Earnings

Last price:
$16.76
Seasonality move :
16.43%
Day range:
$16.63 - $17.12
52-week range:
$15.67 - $73.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
895.26x
P/B ratio:
1.27x
Volume:
378.8K
Avg. volume:
1.3M
1-year change:
-56.27%
Market cap:
$676.9M
Revenue:
$151K
EPS (TTM):
-$5.21

Earnings Data

Next earnings date for KROS
Feb 28
2025
Most recent earnings per share
-$1.41
Missed by $0.13
(Nov 6/2024)
Consensus Estimate
-$1.28
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KROS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $34.2M -- -- -$0.51 --
11/06/2024 Q3 -- $388K -$1.41 -$1.28 -$0.13
08/07/2024 Q2 -- $37K -$1.25 -$1.25 $0.00
05/08/2024 Q1 -- $83K -$1.21 -$1.33 $0.12
02/28/2024 Q4 -- $143K -$1.34 -$1.39 $0.05
11/06/2023 Q3 -- -- -$1.33 -$1.35 $0.02
08/07/2023 Q2 -- -- -$1.27 -$1.35 $0.08
05/04/2023 Q1 -- -- -$1.26 -$1.14 -$0.12
03/03/2023 Q4 -- -- -$1.09 -$1.10 $0.01
11/03/2022 Q3 -- -- -$0.92 -- --
08/04/2022 Q2 -- -- -$1.13 -- --
05/05/2022 Q1 -- -- -$1.01 -- --
03/09/2022 Q4 -- -- -$0.30 -- --
11/04/2021 Q3 -- -- -$0.87 -- --
08/05/2021 Q2 -- -- -$0.67 -- --
05/06/2021 Q1 -- -- -$0.68 -- --
03/25/2021 Q4 -- -- -$0.49 -- --
11/10/2020 Q3 -- -- -$0.60 -- --
08/13/2020 Q2 -- -- -$0.62 -- --
05/22/2020 Q1 -- -- -$0.70 -- --
12/31/2019 Q4 -- -- -$0.18 -- --
09/30/2019 Q3 -- -- -$0.45 -- --
06/30/2019 Q2 -- -- -$0.37 -- --
03/31/2019 Q1 -- -- -$0.41 -- --

Keros Therapeutics Earnings Questions

  • How Much did Keros Therapeutics Generate in Revenue Last Quarter?

    Keros Therapeutics reported $388K worth of top line sales in its most recent quarter.

  • Did Keros Therapeutics Beat Earnings Last Quarter?

    Keros Therapeutics announced earnings per share of -$1.41 which represents a miss of analyst forecast a -$1.28 per share.

  • Is Keros Therapeutics Profitable?

    Keros Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Keros Therapeutics EPS Next Year?

    Keros Therapeutics's earnings are forecast to decrease from -$5.20 per share to -$5.26 per share next year representing a decrease of -3%.

  • When is Keros Therapeutics's Earnings Date?

    Keros Therapeutics's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 25

Power Solutions International [PSIX] is up 27.42% over the past day.

Buy
65
TSLL alert for Dec 25

Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.

Buy
75
SMLR alert for Dec 25

Semler Scientific [SMLR] is up 15.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock